Clinical trial
Compassionate Use of Vorinostat for the Treatment of Patients With Advanced…
NCT00419367 · Merck Sharp & Dohme LLC, Industry · No longer available
Key facts
| NCT number | NCT00419367 |
|---|---|
| Title | Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042) |
| Official title | Compassionate Use of Vorinostat (MK0683) for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Lymphoma, T-Cell, Cutaneous |
| Intervention type | Drug |
| Interventions | Comparator: vorinostat |
| First posted | Jan 8, 2007 |
| Last update posted | Sep 22, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: